GenesisCare, Australia’s largest provider of radiotherapy services, is getting bigger after acquiring Cancer Partners UK for an undisclosed sum.
GenesisCare, which is 46 per cent owned by private equity firm KKR with management holding 13 per cent and about 150 doctors owning the remaining 41 per cent, is looking to create a network of around 25 specialist cancer care centres in the United Kingdom and Western Europe.
Cancer Partners UK (CPUK), which provides overflow support to National Health Service (NHS) hospitals, already operates eight purpose-built cancer treatment centres and GenesisCare plans to add another three in that market.
GenesisCare Managing Director, Dan Collins said: “We can achieve a better result for patients across the UK with a focus on innovation, sharing global best practice and investment in the latest technology and treatment techniques.”
The expansion into the UK comes at a significant time with the company flagging a potential $1 billion initial public offering.